Correlation Between Enliven Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Enliven Therapeutics and ZyVersa Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and ZyVersa is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.39 times more return on investment than ZyVersa Therapeutics. However, Enliven Therapeutics is 2.55 times less risky than ZyVersa Therapeutics. It trades about 0.04 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 1,496 in Enliven Therapeutics on August 27, 2024 and sell it today you would earn a total of 958.00 from holding Enliven Therapeutics or generate 64.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Enliven Therapeutics |
| ZyVersa Therapeutics |
Enliven Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Enliven Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |